Author:
Saad Fred,Clarke Noel,Colombel Marc
Reference107 articles.
1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC CancerBase No. 5. Lyon: IARCPress. Available at: http://www-dep.iarc.fr/globocan/cdrom.htm.
2. Association between androgen deprivation therapy and fracture risk: a population-based cohort study in men with non-metastatic prostate cancer;Smith;Proc Am Soc Clin Oncol,2004
3. Metastatic bone disease: clinical features, pathophysiology and treatment strategies;Coleman;Cancer Treat Rev,2001
4. Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton;Bogdanos;Endocr Relat Cancer,2003
5. Morphometric evidence for bone resorption and replacement in prostate cancer;Clarke;Br J Urol,1991
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献